About this trial
This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue, sleep difficulties, depressive symptoms, and overall quality of life for patients with non-small cell lung cancer and/or their caregivers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
PATIENT ONLY: Diagnosed with stage I-IV non-small cell lung cancer (NSCLC) or esophageal cancer and going to receive at least 3 weeks of thoracic radiotherapy (RT)
PATIENT ONLY: Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2
PATIENT ONLY: Able to read, write and speak English
PATIENT ONLY: Able to provide informed consent
Disqualifiers
PATIENT ONLY: Who have regularly (self-defined) participated in a mind-body practice in the year prior to diagnosis
PATIENT ONLY: Patients who metastatic disease involving the central nervous system
Trial design
Parallel
Treatments tested in this trial
Educational Intervention
Other interventionUndergo dyadic education program
Quality-of-Life Assessment
Other interventionAncillary studies
Questionnaire Administration
Other interventionAncillary studies
Yoga
Procedure/SurgeryUndergo dyadic yoga
Treatment groups
Trial outcomes
Primary outcomes
Patient 6-minute walk test (6MWT)
Descriptive statistics for study variables and potential covariates will be computed and distribution characteristics of the variables will be examined. The difference between dyadic yoga (DY) and dyadic edication (DE) at 3 month follow-up (3MFU) will be tested at a two-sided .05 significance level.
Secondary outcomes
Patient and caregiver quality of life (QOL)
Analyses will be similar to those for the primary outcome, except that we will use a dyadic model assuming additional dependence in outcomes between patient and caregiver outcomes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator